Luxia Ye

489 total citations · 1 hit paper
25 papers, 327 citations indexed

About

Luxia Ye is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luxia Ye has authored 25 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luxia Ye's work include Epigenetics and DNA Methylation (6 papers), Circadian rhythm and melatonin (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Luxia Ye is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Circadian rhythm and melatonin (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Luxia Ye collaborates with scholars based in China, United Kingdom and South Korea. Luxia Ye's co-authors include Zhilong Zheng, Hongyu Zhang, Qingxin Yu, Zhouting Tuo, Dechao Feng, Yanqing Wu, Dengxiong Li, Ke Xu, Wuran Wei and Jian Xiao and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Advanced Science.

In The Last Decade

Luxia Ye

25 papers receiving 324 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies

2025 16 citations Qingxin Yu, Luxia Ye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luxia Ye China	11	172	49	45	40	40	25	327
Tailong Yi China	9	163 0.9×	59 1.2×	45 1.0×	31 0.8×	24 0.6×	14	347
Veronica Sfredel Romania	10	101 0.6×	29 0.6×	33 0.7×	28 0.7×	49 1.2×	25	318
Manini Bhatt India	3	236 1.4×	73 1.5×	28 0.6×	32 0.8×	44 1.1×	4	448
Haiyang Zhao China	11	264 1.5×	86 1.8×	87 1.9×	27 0.7×	35 0.9×	21	408
Xue Peng China	12	219 1.3×	34 0.7×	23 0.5×	31 0.8×	29 0.7×	21	348
Huan Pan China	13	158 0.9×	38 0.8×	22 0.5×	26 0.7×	63 1.6×	28	314
Xiaohua Tan China	11	176 1.0×	81 1.7×	44 1.0×	30 0.8×	17 0.4×	26	439
Hongde Xu China	16	290 1.7×	76 1.6×	43 1.0×	27 0.7×	59 1.5×	26	541
Xiya Shen China	10	171 1.0×	46 0.9×	63 1.4×	19 0.5×	24 0.6×	13	391

Countries citing papers authored by Luxia Ye

Since Specialization

Citations

This map shows the geographic impact of Luxia Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luxia Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luxia Ye more than expected).

Fields of papers citing papers by Luxia Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luxia Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luxia Ye. The network helps show where Luxia Ye may publish in the future.

Co-authorship network of co-authors of Luxia Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Luxia Ye. A scholar is included among the top collaborators of Luxia Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luxia Ye. Luxia Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Dengxiong, Zhipeng Wang, Qingxin Yu, et al.. (2025). Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease. Advanced Science. 12(13). e2407715–e2407715. 4 indexed citations

Wang, Zhipeng, Jie Wang, Luxia Ye, et al.. (2025). Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistance. Journal of Pharmaceutical Analysis. 15(9). 101232–101232. 5 indexed citations

Li, Dengxiong, Jie Wang, Xinrui Li, et al.. (2025). Interactions between radiotherapy resistance mechanisms and the tumor microenvironment. Critical Reviews in Oncology/Hematology. 210. 104705–104705. 1 indexed citations

Li, Dengxiong, Jie Wang, Ruicheng Wu, et al.. (2025). Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedside. Metabolism. 173. 156375–156375. 1 indexed citations

Yu, Qingxin, et al.. (2024). SLC39A14 promotes the development of esophageal squamous cell carcinoma through PI3K/Akt/mTOR signaling pathway. International Immunopharmacology. 146. 113831–113831. 3 indexed citations

Wang, Zhipeng, Luxia Ye, Ruicheng Wu, et al.. (2024). Basic helix–loop–helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases. Burns & Trauma. 13. tkae075–tkae075. 7 indexed citations

Jiang, Zhiwei, Dengxiong Li, Ruicheng Wu, et al.. (2024). The application of 3D printing technology in tumor radiotherapy in the era of precision medicine. Applied Materials Today. 40. 102368–102368. 5 indexed citations

Tuo, Zhouting, Ying Zhang, Jie Wang, et al.. (2024). Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review. Pharmacological Research. 206. 107302–107302. 8 indexed citations

Li, Dengxiong, Zhouting Tuo, Jie Wang, et al.. (2024). The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways. Cell Communication and Signaling. 22(1). 405–405. 15 indexed citations

10.

Yu, Qingxin, et al.. (2024). GREM1 may be a biological indicator and potential target of bladder cancer. Scientific Reports. 14(1). 23280–23280. 3 indexed citations

11.

Li, Dengxiong, Qingxin Yu, Zhouting Tuo, et al.. (2024). Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives. Chinese Journal of Cancer Research. 36(6). 596–615. 7 indexed citations

12.

Li, Dengxiong, Qingxin Yu, Zhouting Tuo, et al.. (2024). Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives. Redox Biology. 73. 103208–103208. 40 indexed citations

13.

Li, Dengxiong, Xinrui Li, Qingxin Yu, et al.. (2024). Advancements and challenges of R-loops in cancers: Biological insights and future directions. Cancer Letters. 610. 217359–217359. 9 indexed citations

14.

Li, Dengxiong, Qingxin Yu, Ruicheng Wu, et al.. (2024). Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based Interventions. Aging and Disease. 16(2). 645–645. 10 indexed citations

15.

Feng, Dechao, Jie Wang, Ruicheng Wu, et al.. (2024). SKA3 targeted therapies in cancer precision surgery: bridging bench discoveries to clinical applications – review article. International Journal of Surgery. 110(4). 2323–2337. 3 indexed citations

16.

Feng, Dechao, Li Li, Dengxiong Li, et al.. (2023). Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients. European journal of medical research. 28(1). 245–245. 11 indexed citations

17.

Zheng, Jing‐Min, et al.. (2021). KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 11. 686678–686678. 11 indexed citations

18.

Xu, Ke, Xiaokun Li, Hongyu Zhang, et al.. (2020). Exogenous platelet-derived growth factor improves neurovascular unit recovery after spinal cord injury. Neural Regeneration Research. 16(4). 765–765. 22 indexed citations

19.

Zheng, Zhilong, Yajiao Zhou, Luxia Ye, et al.. (2019). Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury. Experimental Neurology. 324. 113138–113138. 43 indexed citations

20.

Li, Zhengmao, Ting Jiang, Ke Xu, et al.. (2019). Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells. Cellular and Molecular Neurobiology. 40(4). 587–602. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact